MIR3158-1

Across TCGA pan-cancer cohorts, MIR3158-1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR3158-1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR3158-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3158-1 expression acts as an unfavorable survival marker.

UCS, CHOL, and UVM are the cancer types where MIR3158-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	III,IV	0.102	0.591	<.001	72	view →
CHOL	OS	Tertile	II,III,IV	0.140	0.748	<.001	45	view →
UVM	OS	Tertile	All	0.337	0.816	<.001	45	view →
LIHC	OS	Tertile	II,III,IV	0.200	0.624	.004	45	view →
LUAD	DFS	Tertile	III,IV	0.177	0.680	.002	18	view →
SARC	DFS	Tertile	All	0.195	0.597	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR3158-1–UCS (OS)

Open the UCS breakdown →